Medical Letter on the CDC & FDA articles from April 2009

Medical Letter on the CDC & FDA archives from April 2009

Data on hepatocellular cancer described by researchers at Food & Drug Administration.
April 5, 2009... In this recent report published in the journal Oncologist, researchers in the United States conducted a study "To describe the U. S. Food and Drug Administration (FDA) review and approval of sorafenib (Nexavar (R); Bayer Pharmaceuticals Corp.,...

New research on HIV/AIDS from University of Lille summarized.
April 5, 2009... According to recent research from France, "Since the discovery of MK-0518 (raltegravir, the first FDA-approved integrase inhibitor) in October 2007, Merck Co. researchers have continued to patent original new heterocycles related to raltegravir...

Royal Society of Chemistry Identifies NIMBUS[R] as a Next-Generation Biomaterial.
April 5, 2009... Chemistry World, a publication of Great BritainEs distinguished Royal Society of Chemistry, has cited Quick-MedEs (OTCBB:QMDT) novel NIMBUS[R] antimicrobial materials technology as onext generationo in advanced wound care. The article, which...

Data on surgery published by M.J. Campbell and colleagues.(Report)
April 5, 2009... "Randomized clinical trial. This study is evaluates whether the use of a cervical collar after single-level anterior cervical fusion with plating increases the fusion rate and improved clinical outcomes," scientists in the United States report...

Reports from A. Valero and co-researchers add new data to research in allergies.
April 5, 2009... "Rupatadine (Rupafin (R)), a novel antihistamine approved recently in Europe for the treatment of allergic rhinitis (AR) and chronic idiopathic urticaria in patients aged >= 12 years, has been shown to be highly efficacious, and as safe and...

Research findings from Korea University update understanding of Escherichia coli.
April 5, 2009... According to recent research published in the journal Biochemical and Biophysical Research Communications, "Here, we characterized released-exopolysaccharides (r-EPS) from Lactobacillus acidophilus A4 with the goal of identifying natural...

Report summarizes legionnaire disease study findings from University of Louisville, Medical Department.
April 5, 2009... "To examine the role of the PmrA/PmrB two-component system (TCS) of Legionella pneumophila in global gene regulation and in intracellular infection, we constructed pmrA and pmrB isogenic mutants by allelic exchange. Genome-wide microarray gene...

Tufts University, Medical Department reports research in legionnaire disease.
April 5, 2009... "Mouse-derived macrophages have the unique ability to restrict or permit Legionella pneumophila intracellular growth. The common inbred mouse strain C57BL/6J (B6) restricts L. pneumophila growth, whereas macrophages derived from A/J mice allow...

Research from University of Illinois provides new data on plague.
April 5, 2009... "Interleukin-10 (IL-10)-deficient mice are resistant to several pathogens, including Yersinia pestis. Surprisingly, we observed that heterozygous IL-10(+/-) mice also survive high-dose intravenous infection with Y. pestis KIM5 (Pgm(-)),"...

Research from University of Minnesota in west nile virus provides new insights.
April 5, 2009... According to recent research from the United States, "Nestling birds have been hypothesized to be important hosts for mosquito-borne arboviruses, but the role of nestlings for West Nile virus (WNV) amplification remains unclear. We sampled...

Findings from University of North Carolina in yersinia reported.
April 5, 2009... "Many proteins secreted by the type V secretion system (autotransporters) have been linked to virulence in gram-negative bacteria. Several putative conventional autotransporters are present in the Yersinia pestis genome, but only one, YapE, is...

Institute of Microbiology details research in legionnaire disease cell biology.
April 5, 2009... A new study, 'The inositol polyphosphate 5-phosphatase OCRL1 restricts intracellular growth of Legionella, localizes to the replicative vacuole and binds to the bacterial effector LpnE,' is now available. "Legionella pneumophila, the causative...

ABB CONCISE Optical Group Takes Second Warehouse Live with IRMS Warehouse Software.
April 5, 2009... In an ongoing effort to advance productivity and increase efficiency through real-time inventory management, ABB CONCISE has successfully implemented UppEs award-winning IRMS software solution in the second of three warehouse operations (see...

Scientists at Medical College of Georgia, Medical College report research in cell therapy.
April 12, 2009... According to recent research from the United States, "Stroke remains a significant clinical unmet condition, with only 3% of ischemic patient population benefiting from the thrombolytic drug tissue plasminogen activator largely because of the...

Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents.
April 12, 2009... Forest Laboratories, Inc. (NYSE:FRX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for Lexapro (escitalopram oxalate) for the acute and maintenance treatment of...

New kidneys study findings have been published by scientists at Food & Drug Administration.
April 12, 2009... "The US Food and Drug Administration (FDA) is currently developing a guidance for industry to replace a previous guidance, ''Pharmacokinetics in Patients With Impaired Renal Function-Study Design, Data Analysis, and Impact on Dosing and...

New life sciences study findings have been reported by researchers at University of California.
April 12, 2009... According to recent research published in the journal Thyroid, "FDA Guidance for pharmacokinetic (PK) testing of levothyroxine (L-T-4) for interbrand bioequivalence has evolved recently. Concerns remain about efficacy and safety of the current...

Recent studies by R.R. Ratan and co-authors add new data to life sciences findings.
April 12, 2009... According to a study from the United States, "Stroke is the leading cause of disability in the United States, and yet no definitive interventions can drive the nervous system beyond its measurable but often limited spontaneous recovery....

New wheat disease could spread faster than expected.
April 12, 2009... Both plant and human diseases that can travel with the wind have the potential to spread far more rapidly than has been understood, according to a new study, in findings that pose serious concerns not only for some human diseases but also a new...

Revolutions Medical Corporation New Corporate Headquarters.
April 12, 2009... Since the Revolutions Medical Corporation's (OTCBB: RMCP)recent FDA 510K Clearance for our proprietary RevVac safety syringe, the company has decided to move to a new Corporate Sales Headquarters in Charleston, S.C....

New breast cancer research from F. Chibon et al outlined.
April 19, 2009... According to recent research from Bordeaux, France, "Most Her2 testing guidelines recommend that all cases scoring Her2 2+ by immunohistochemistry should be analyzed by fluorescent in situ hybridization (FISH) to determine HER2 status to...

Studies from Food & Drug Administration in the area of clinical trial research published.(Report)
April 19, 2009... "This study aimed to track the inclusion of women in clinical trials for new drugs approved by the Food and Drug Administration (FDA) between 2000 and 2002 and to evaluate the extent of analyses by sex. Data were extracted from FDA reviewers'...

New HIV/AIDS data have been reported by S. Sayana and co-authors.
April 19, 2009... According to recent research from the United States, "Maraviroc is a small molecule and a member of a new class of antiretroviral compounds known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into the cell...

New life sciences study results reported from Baskent University, Medical Department.(Clinical report)
April 19, 2009... "LPG endermologie is a FDA-approved massage system in use worldwide for cellulite treatment that lacks clinical study. To determine the efficacy and safety of LPG endermologie in treating cellulite," scientists in Ankara, Turkey report (see...

Reports summarize life sciences research from University of Texas.
April 19, 2009... "Recent changes in U.S. Food and Drug Administration (FDA) labeling and news reports of lawsuits resulting in million-dollar settlements understandably may deter gynecologists from prescribing the transdermal contraceptive patch Ortho Evra...

New research on Escherichia coli from University of Arizona summarized.
April 19, 2009... According to recent research from the United States, "Heating meat at high temperature and/or for a long time to kill foodborne pathogens increases the formation of potentially carcinogenic heterocyclic amines. To overcome this problem, 1%...

New Version of LDRA Tool Suite Provides First End-to-End Software Verification Solution.
April 19, 2009... LDRA, the leading provider of automated software verification, source code analysis, and test tools, has launched v8.0 of the LDRA tool suite, the first fully automated end-to-end solution for software verification support. With the integration...

MGT Capital Investments, Inc. Reports Fiscal 2008 Financial Results and Provides an Update on Recent Developments.(Financial report)
April 19, 2009... MGT Capital Investments, Inc. (NYSE AMEX: MGT), a holding company, reported financial results for the year ended December 31, 2008 and provided an update on strategic milestones (see also MGT Capital Investments, Inc.). For the year ended...

Setton Pistachio of Terra Bella, Inc. Announces Nationwide Recall of Pistachios Because of Possible Health Risk.
April 19, 2009... Setton Pistachio of Terra Bella, Inc. announced that it is voluntarily recalling from nationwide distribution specific lots of bulk roasted shelled pistachios and 2,000 lbs., 1,700 lbs., 1,800 lbs. and 1,000 lbs. tote bags of roasted inshell...

Data on anti-infectives published by T.D. Nguyen and colleagues.
April 26, 2009... "The findings of increased all-cause mortality associated with cefepime therapy reported in a 2007 meta-analysis by Yahav and colleagues in The Lancet Infectious Disease prompted an early communication by the Food Drug Administration (FDA). The...

Research findings from C.H. Takimoto et al update understanding of drug development.(Clinical report)
April 26, 2009... " To review the potential impact of Phase 0 trials conducted under the United States Food and Drug Administration (FDA) exploratory IND guidance on oncology drug development. The FDA's exploratory IND guidance document is examined in detail...

New findings in life sciences described by J.F. Chabas and co-researchers.
April 26, 2009... "Accumulating evidence indicates that in addition to its immunosuppressant properties, FK506 (tacrolimus), an FDA-approved molecule, promotes nerve regeneration. However, the neuroprotective and neurotrophic effects of this molecule on...

New research on life sciences from North Carolina State University summarized.
April 26, 2009... "There is great interest in finding human genes expressed through pharmaceutical intervention, thus opening a genomic window into benefit and side-effect profiles of a drug. Human insight gained from FDA-required animal experiments has...

Research from S. Anderson and co-researchers in the area of life sciences published.
April 26, 2009... According to recent research published in the journal Chemical Research in Toxicology, "The FDA issued a guidance on the safety testing of metabolites in February 2008, in which they stated that metabolites of concern are those that are...

Scientists at Purdue University target Escherichia coli.
April 26, 2009... According to a study from the United States, "Bacteriophage Phi V10 is a temperate phage, which specifically infects Escherichia coli O157:H7. The nucleotide sequence of the Phi V10 genome is 39 104 bp long and contains 55 predicted genes." ...

AirStrip OB[TM] Receives FDA Clearance on BlackBerry[TM].
April 26, 2009... AirStrip Technologies announced that its signature product, AirStrip OB™, has received FDA clearance for use on the BlackBerry™ (see also AirStrip Technologies, L.P.). Airstrip OB is the innovative mobile medical software...

Innovative iPhone[TM] Medical Application Granted FDA Clearance.
April 26, 2009... AirStrip Technologies, a pioneer in mobile medical software applications, announced that it has received FDA clearance to release the AirStrip OB™ application for use on the iPhone, and that the application is now available for download to...

LDR Announces FDA Clearance of Its ROI-A[TM] ALIF Device.
April 26, 2009... LDR, a total spine solution company, announced that it received FDA clearance on Feb. 2 to market its ROI-A™ implant as an anterior lumbar interbody fusion (ALIF) device. Previously cleared in April 2008 as a partial vertebral body...

Siemens Offers Life Science Solutions Design Guide for Consulting Engineers.
April 26, 2009... Siemens Building Technologies, Inc. is offering a new Life Science Solutions Design Guide written expressly for consulting engineers and other professionals who are looking to design and specify effective and more energy-efficient laboratory...

Voler Systems Continues Investments and Expands Services.
April 26, 2009... Voler Systems (http://www.volersystems.com/) has launched a "Quality System for Medical Device Innovation Program" which provides full-service consulting from concept and design to production of devices for human use. The current economic...

Pistachio Growers and Processors Announce New Web Site to Inform Consumers, Retailers of Pistachio Brands Not Containing Pistachios From Setton Pistachio of Terra Bella, Inc.(Website overview)
April 26, 2009... Pistachio growers and processors announced a new Web site - www.pistachiorecall.org - that lists specific pistachio products and brands that do not contain pistachios from Setton Pistachio of Terra Bella, Inc (see also Western Pistachio...